In a study by Propeller Health and NorthShore University HealthSystem, patients using Propeller Health to manage their asthma experienced a significant decline in rescue inhaler use and higher medication adherence…
Propeller Health announced today it will begin distributing in Japan through collaboration with Novartis by connecting Propeller’s digital health platform to two of Novartis’ medications. According to a release, Enerzair Breezhaler…
Propeller Health will co-package the Propeller digital health platform with Novartis’ Enerzair Breezhaler, a recently approved medication developed to treat uncontrolled asthma, the company announced today. According to a release, the…
Propeller Health has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to connect patients using a Symbicort Inhaler to its digital health platform, the company announced today….
Propeller Health announced today that its digital health platform for asthma and COPD has been included in Express Script’s first formulary for digital and mobile health apps and devices. According to a…
Propeller Health is partnering with Orion Corporation, a digital therapeutics company, to connect its Easyhaler line of inhalers for asthma and COPD to Propeller’s digital medicine platform. “This partnership with Orion…
Propeller Health is being acquired by ResMed, a health company based in San Diego that specializes in cloud-connected medical devices and out-of-hospital software-as-a-service business solutions, the company announced today. “ResMed shares…
Propeller Health announced recently that it’s collaborating with Anthem Blue Cross and Blue Shield to help improve health outcomes for Ohio consumers enrolled in Anthem’s Medicare Advantage health plans who have…
Along with the $20 million funding round announced last week, Propeller Health announced recently that McKesson Ventures also has made an investment in the company. According to a release, the undisclosed…
Propeller Health announced today that it has raised $20 million to support its investment in its pipeline of digital therapeutics and additional connected devices for the treatment of chronic respiratory disease….
